Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 47Squamous Cell Carcinoma of Head and Neck 30Head and Neck Neoplasms 17Colonic Neoplasms 15Rectal Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 7Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Squamous Cell 4Recurrence 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma 3Oropharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Laryngeal Diseases 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Tongue Neoplasms 1Stomach Neoplasms 1Rectal Diseases 1Radiation Injuries 1Precancerous Conditions 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Intestinal Neoplasms 1

Interventions

Bevacizumab 5Leucovorin 4Irinotecan 4Fluorouracil 4Capecitabine 2napabucasin 1encorafenib 1Simvastatin 1Oxaliplatin 1Oviposition 1Levoleucovorin 1Drug Therapy 1Drainage 1Cetuximab 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Intestinal Neoplasms × Cetuximab × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡